Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
Deng T, Li J, He B, Chen B, Liu F, Chen Z, Zheng J, Shi Z, Zhang T, Deng L, Yu H, Yang J, Wu L, Shan Y, Yu Z, Chen X, Wang Y, Chen G.
Deng T, et al.
Hepatol Int. 2022 Feb;16(1):99-111. doi: 10.1007/s12072-021-10279-3. Epub 2022 Jan 22.
Hepatol Int. 2022.
PMID: 35064546